US Stock MarketDetailed Quotes

ARTH ARCH THERAPEUTICS INC

Watchlist
  • 1.050000
  • -0.130000-11.02%
15min DelayClose Apr 19 16:00 ET
4.98MMarket Cap-750P/E (TTM)

ARCH THERAPEUTICS INC Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
(Q3)Jun 30, 2022
(Q2)Mar 31, 2022
Total revenue
632.58%45.87K
383.80%75.72K
2,423.44%39.52K
112.31%13.29K
432.08%16.65K
33.33%6.26K
35.34%15.65K
0.06%1.57K
6.26K
-68.70%3.13K
Operating revenue
632.58%45.87K
383.80%75.72K
2,423.44%39.52K
112.31%13.29K
432.08%16.65K
33.33%6.26K
35.34%15.65K
0.06%1.57K
--6.26K
-68.70%3.13K
Cost of revenue
33.86%23.61K
51.81%78.16K
18,376.98%23.28K
8.10%18.53K
7.39%18.72K
5.02%17.64K
95.91%51.49K
-99.22%126
17.14K
72.54%17.43K
Gross profit
295.72%22.26K
93.19%-2.44K
1,027.50%16.24K
51.87%-5.24K
85.57%-2.06K
5.97%-11.37K
-143.51%-35.84K
109.85%1.44K
-10.88K
-13,919.61%-14.3K
Operating expense
19.98%1.52M
-11.12%5.04M
-6.76%1.35M
1.31%1.01M
-18.03%1.42M
-15.58%1.26M
-10.84%5.67M
-15.65%1.44M
-40.28%996.06K
-0.79%1.74M
Selling and administrative expenses
18.90%1.31M
-3.29%4.37M
-5.45%1.15M
4.05%870.05K
3.63%1.25M
-12.68%1.1M
-9.78%4.52M
-14.02%1.21M
-38.98%836.22K
-9.77%1.21M
Research and development costs
27.33%205.58K
-41.83%670.88K
-13.61%199.75K
-13.01%139.05K
-67.66%170.63K
-31.18%161.45K
-14.76%1.15M
-23.27%231.21K
-46.28%159.85K
28.51%527.66K
Operating profit
-17.16%-1.49M
11.64%-5.04M
7.79%-1.33M
-0.73%-1.01M
18.58%-1.43M
15.50%-1.28M
10.48%-5.71M
16.45%-1.44M
39.63%-1.01M
-0.02%-1.75M
Net non-operating interest income expense
-126.39%-1.19M
-446.08%-3.1M
-152.20%-1.13M
-1,927.50%-808.77K
-1,510.03%-635.19K
-1,200.09%-524.31K
-276.70%-567.05K
-1,009.32%-447.38K
0.74%-39.89K
3.19%-39.45K
Non-operating interest expense
126.39%1.19M
446.08%3.1M
152.20%1.13M
1,927.50%808.77K
1,510.03%635.19K
1,200.09%524.31K
276.70%567.05K
1,009.32%447.38K
-0.74%39.89K
-3.19%39.45K
Other net income (expense)
15.82%1.16M
0
15.82%1.16M
248.22%1M
0
1M
Gain on sale of security
----
15.82%1.16M
--0
----
15.82%1.16M
----
817.90%1M
--0
----
--1M
Income before tax
-48.98%-2.68M
-32.35%-6.98M
-30.11%-2.46M
-74.16%-1.82M
-14.19%-902.48K
-16.12%-1.8M
15.46%-5.28M
-6.99%-1.89M
31.58%-1.05M
55.88%-790.32K
Income tax
Net income
-48.98%-2.68M
-32.35%-6.98M
-30.11%-2.46M
-74.16%-1.82M
-14.19%-902.48K
-16.12%-1.8M
15.46%-5.28M
-6.99%-1.89M
31.58%-1.05M
55.88%-790.32K
Net income continuous Operations
-48.98%-2.68M
-32.35%-6.98M
-30.11%-2.46M
-74.16%-1.82M
-14.19%-902.48K
-16.12%-1.8M
15.46%-5.28M
-6.99%-1.89M
31.58%-1.05M
55.88%-790.32K
Minority interest income
Net income attributable to the parent company
-48.98%-2.68M
-32.35%-6.98M
-30.11%-2.46M
-74.16%-1.82M
-14.19%-902.48K
-16.12%-1.8M
15.46%-5.28M
-6.99%-1.89M
31.58%-1.05M
55.88%-790.32K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-48.98%-2.68M
-32.35%-6.98M
-30.11%-2.46M
-74.16%-1.82M
-14.19%-902.48K
-16.12%-1.8M
15.46%-5.28M
-6.99%-1.89M
31.58%-1.05M
55.88%-790.32K
Basic earnings per share
60.42%-0.57
48.41%-2.27
65.98%-0.524
-61.36%-1.42
-5.97%-0.71
-9.92%-1.44
26.67%-4.4
23.00%-1.54
56.00%-0.88
66.50%-0.67
Diluted earnings per share
60.42%-0.57
48.41%-2.27
65.98%-0.524
-61.36%-1.42
-5.97%-0.71
-9.92%-1.44
26.67%-4.4
23.00%-1.54
56.00%-0.88
66.50%-0.67
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022(Q3)Jun 30, 2022(Q2)Mar 31, 2022
Total revenue 632.58%45.87K383.80%75.72K2,423.44%39.52K112.31%13.29K432.08%16.65K33.33%6.26K35.34%15.65K0.06%1.57K6.26K-68.70%3.13K
Operating revenue 632.58%45.87K383.80%75.72K2,423.44%39.52K112.31%13.29K432.08%16.65K33.33%6.26K35.34%15.65K0.06%1.57K--6.26K-68.70%3.13K
Cost of revenue 33.86%23.61K51.81%78.16K18,376.98%23.28K8.10%18.53K7.39%18.72K5.02%17.64K95.91%51.49K-99.22%12617.14K72.54%17.43K
Gross profit 295.72%22.26K93.19%-2.44K1,027.50%16.24K51.87%-5.24K85.57%-2.06K5.97%-11.37K-143.51%-35.84K109.85%1.44K-10.88K-13,919.61%-14.3K
Operating expense 19.98%1.52M-11.12%5.04M-6.76%1.35M1.31%1.01M-18.03%1.42M-15.58%1.26M-10.84%5.67M-15.65%1.44M-40.28%996.06K-0.79%1.74M
Selling and administrative expenses 18.90%1.31M-3.29%4.37M-5.45%1.15M4.05%870.05K3.63%1.25M-12.68%1.1M-9.78%4.52M-14.02%1.21M-38.98%836.22K-9.77%1.21M
Research and development costs 27.33%205.58K-41.83%670.88K-13.61%199.75K-13.01%139.05K-67.66%170.63K-31.18%161.45K-14.76%1.15M-23.27%231.21K-46.28%159.85K28.51%527.66K
Operating profit -17.16%-1.49M11.64%-5.04M7.79%-1.33M-0.73%-1.01M18.58%-1.43M15.50%-1.28M10.48%-5.71M16.45%-1.44M39.63%-1.01M-0.02%-1.75M
Net non-operating interest income expense -126.39%-1.19M-446.08%-3.1M-152.20%-1.13M-1,927.50%-808.77K-1,510.03%-635.19K-1,200.09%-524.31K-276.70%-567.05K-1,009.32%-447.38K0.74%-39.89K3.19%-39.45K
Non-operating interest expense 126.39%1.19M446.08%3.1M152.20%1.13M1,927.50%808.77K1,510.03%635.19K1,200.09%524.31K276.70%567.05K1,009.32%447.38K-0.74%39.89K-3.19%39.45K
Other net income (expense) 15.82%1.16M015.82%1.16M248.22%1M01M
Gain on sale of security ----15.82%1.16M--0----15.82%1.16M----817.90%1M--0------1M
Income before tax -48.98%-2.68M-32.35%-6.98M-30.11%-2.46M-74.16%-1.82M-14.19%-902.48K-16.12%-1.8M15.46%-5.28M-6.99%-1.89M31.58%-1.05M55.88%-790.32K
Income tax
Net income -48.98%-2.68M-32.35%-6.98M-30.11%-2.46M-74.16%-1.82M-14.19%-902.48K-16.12%-1.8M15.46%-5.28M-6.99%-1.89M31.58%-1.05M55.88%-790.32K
Net income continuous Operations -48.98%-2.68M-32.35%-6.98M-30.11%-2.46M-74.16%-1.82M-14.19%-902.48K-16.12%-1.8M15.46%-5.28M-6.99%-1.89M31.58%-1.05M55.88%-790.32K
Minority interest income
Net income attributable to the parent company -48.98%-2.68M-32.35%-6.98M-30.11%-2.46M-74.16%-1.82M-14.19%-902.48K-16.12%-1.8M15.46%-5.28M-6.99%-1.89M31.58%-1.05M55.88%-790.32K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -48.98%-2.68M-32.35%-6.98M-30.11%-2.46M-74.16%-1.82M-14.19%-902.48K-16.12%-1.8M15.46%-5.28M-6.99%-1.89M31.58%-1.05M55.88%-790.32K
Basic earnings per share 60.42%-0.5748.41%-2.2765.98%-0.524-61.36%-1.42-5.97%-0.71-9.92%-1.4426.67%-4.423.00%-1.5456.00%-0.8866.50%-0.67
Diluted earnings per share 60.42%-0.5748.41%-2.2765.98%-0.524-61.36%-1.42-5.97%-0.71-9.92%-1.4426.67%-4.423.00%-1.5456.00%-0.8866.50%-0.67
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg